Current Working Groups
EFOMP “Breast Tomosynthesis QC Protocol”.
The WG will operate from April 2019 to March 2021.
The rationale of the WG is to develop a QC protocol for DBT systems. It is envisioned that this protocol could prevent the proliferation of other testing protocols with diverse methods of measurement and limiting values. The DBT QC protocol should incorporate the new universal breast dosimetry model which is in development by a joint AAPM-EFOMP WG. Additionally, task-based image quality methods are planned to be included into practical QC procedures by the WG.
EFOMP “Artificial Intelligence (AI)”.
The WG will operate from Jun 2019 to Apr 2021.
The rationale of the WG: Big data and deep learning will profoundly change various areas of professions and research in the future. This will also happen in medicine and medical imaging in particular. Quantitative aspects of data validation, QC and system modelling for the future AI methods are positioned firmly in the field of Medical Physics profession. It is our interest to ensure that our professional education, continuous training and competence will follow this significant global development.
EFOMP “Angiographic and fluoroscopic systems - QC protocol”.
The WG will operate under Scientific Committee from Jun 2019 to Jun 2021.
The rationale of the WG: There is lack of an harmonized procedure to test angiographic and fluorosopic equipment. Some of the tests proposed still used are out-of-date and meaningless. Manufacturers are organizing a joint effort to produce an IEC standard to test the equipment. It is envisioned that this protocol could prevent the proliferation of other testing protocols with diverse methods of measurement and limiting values. New strategies to evaluate clinical image quality will be investigated and eventually included in the protocol.
EFOMP "PET/CT AND PET/MR QC Protocol".
The WG will operate under Scientific Committee from 1st February 2020 to 1st February 2022.
The rationale of the WG: The literature on routine Quality Controls in PET/CT scanners is out-of-date or no more valid, especially in the light of the new PET/CT tomographs. The scenario for PET/MRI quality controls is even worse, because of the lack of dedicated quality controls recom-mendations on these hybrid scanners. Thus, there is a demanding need for guidelines that identify a set of routine quality controls to perform on up-to-date PET/CT and PET/MRI scanners. The set of quality controls devised should have the characteristics of being simple and easy to realize. Reference and tolerance values will also be defined. The execution of these QC would guarantee the operation of PET/CT and PET/MRI scanners under optimal conditions ensuring the best per-formance in routine clinical tasks.
Joint EFOMP-AAPM WG "Breast dosimetry".
The rationale of the WG: development and dissemination of a new model and methology to etsimate the breast average glandular dose (AGD)
- Development of a breast dose method
- Development of a breast dosimetry phantom
Joint EFOMP-ESTRO physics committee WG "Core curriculum revision for Medical Physicists working in Radiotherapy".
The WG will operate from September 2019 to March 2021. EFOMP is represented by the European Matters, Education & Training, Professional Matters and Scientific Committees of EFOMP.
The rationale of the WG is to update the current core curriculum
EFOMP "Role of MPE in clinical trials"
The WG will operate under Scientific Committee from September 2020 to September 2022.
The rationale of the WG: To develop a consensus guidance document for the work MPEs do in clinical trials across Europe.
EFOMP "The involvement of Medical Physics Experts in the life cycle of medical devices".
The WG will operate under Professional Matters Committee from 1st of December 2020 to 1st December 2022.
The rationale of the WG: This working group will work together to publish EFOMP Policy Statement no 17: The Involvement of Medical Physics Experts in the life cycle of medical devices. This policy statement will inform healthcare managers and government officials on the many benefits of having MPEs involved in this process and identify some of the key areas where our expertise is invaluable over the life cycle of medical devices from specification, procurement, acceptance testing and ongoing quality assurance.
Joint AAPM-ESTRO-EFOMP "FLASH (ultra-high dose rate) radiation dosimetry" (TG359).
The WG will review the uncertainty in determining the dose and need for standardization in dosimetry for FLASH beams to be used in experiments, research and potentially in pre-clinical applications.
- Assess the factors that would affect the beam dosimetric characteristics in FLASH mode, compared to standard delivery.
- Assess the suitability of radiation measurement equipment (ion chambers, film, diodes, Faraday cap, etc) for FLASH mode.
- Provide general guidelines on calibration, dosimetry and reporting of beams in FLASH mode.
Composition Chair Dimitris Mihailidis (AAPM) Vice chair Yolanda Prezado (EFOMP)
Past Working Groups
EFOMP “Revision of EFOMP PS14 - Safety of MRI”.
The WG operated from June 2019 to June 2020.
The rationale of the WG was to outline the development of a Safety Management System for MRI units. The Policy Statement can help eliminate or at least minimize accidents or incidents in the magnetic resonance environment and is recommended as a step towards harmonisation of safety of workers, patients, and the general public regarding the use of magnetic resonance imaging systems in diagnostic and interventional procedures.
Joint AAPM Task Group 246 and EFOMP
The rationale of the WG: Estimating Patient Organ Dose with Computed Tomography: A Review of Present Methodology and Required DICOM Information